The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients

OBJECTIVE:The p21 gene is thought to play a central role in tumor suppression. The aim of this study was to examine the clinicopathological role of p21 and p53 in esophageal squamous cell carcinomas.METHODS:The expression of p21 and p53 proteins in 153 Chinese patients (131 men, 22 women) with resected esophageal squamous cell carcinomas was investigated by the immunohistochemical method. Correlation between p21 and p53 expression and clinicopathological features was examined.RESULTS:The expression of p21 and p53 was detected in 70% and 64% of the tumors, respectively. The staining of p21 and p53 was also found in squamous carcinoma in situ, dysplasia, and nontumor epithelium. p21 expression was often weak in the suprabasal cells and found in better differentiated tumors. There was no significant correlation between the expression of p21 and the abnormal accumulation of p53. The prognosis of the patients depended on the size, stage, and p21 expression of the lesion. In stage III lesions with tumor diameter ≤7.5 cm (n = 93), patients with loss of p21 expression had better survival. The survival rates of patients were worse if they had expression of both p21 and p53.CONCLUSIONS:Thus, p21 and p53 had prognostic value for esophageal squamous cell carcinomas. Loss of p21 expression was shown without p53 alternations, indicating that other mechanisms are also involved in turning off the gene. The pattern of p21 and p53 expression predicts an aggressive clinical course of esophageal squamous cell carcinomas.

[1]  S. J. Darnton,et al.  Expression of p53 protein in oesophageal carcinoma: Clinicopathological correlation and prognostic significance , 1994, The British journal of surgery.

[2]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[3]  R. Hardwick,et al.  Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  S. Semba,et al.  Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression , 1997, Pathology international.

[5]  B. Vogelstein,et al.  Absence of WAF1 mutations in a variety of human malignancies. , 1994, Blood.

[6]  S. Dergham,et al.  Relationship of family cancer history to the expression of P53, P21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma , 1997, International journal of pancreatology : official journal of the International Association of Pancreatology.

[7]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[8]  J. Wong,et al.  Prognostic implication of proliferative markers MIB‐1 and PC10 in esophageal squamous cell carcinoma , 1996, Cancer.

[9]  F. Borchard,et al.  P53 protein expression and prognosis in squamous cell carcinoma of the esophagus , 1994, Cancer.

[10]  King-YinLam,et al.  Pathology of esophageal cancers:local experience and current insights , 1997 .

[11]  A. Giordano,et al.  p21waf1/cip1mda-6 expression in non-small-cell lung cancer: relationship to survival. , 1998, American journal of respiratory cell and molecular biology.

[12]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[13]  H. Nekarda,et al.  Prognostic value of DNA index, S‐phase fraction and p53 protein accumulation after surgical resection of esophageal squamous‐cell carcinomas in Thailand , 1995, International journal of cancer.

[14]  G. Tamura,et al.  Aberrations of tumor‐suppressor genes (p53, apc, mcc and Rb) in esophageal squamous‐cell carcinoma , 1994, International journal of cancer.

[15]  M. Monden,et al.  p21(Waf1/Cip1) and p53 protein expression in breast cancer. , 1997, American journal of clinical pathology.

[16]  G. Yang,et al.  Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high‐risk area in northern China , 1997, International journal of cancer.

[17]  J. Wong,et al.  Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness? , 1997, European journal of cancer.

[18]  G. Viale,et al.  p53 protein accumulation and p53 gene mutation in esophageal carcinoma , 1997, Cancer.

[19]  M. Furihata,et al.  Prognostic significance of human papillomavirus genomes (type‐16, ‐18) and aberrant expression of p53 protein in human esophageal cancer , 1993, International journal of cancer.

[20]  P. Chikhlikar,et al.  Clinical significance of p53, nm23, and bcl‐2 in T3–4N1M0 oesophageal carcinoma: An immunohistochemical approach , 1997, Journal of surgical oncology.

[21]  W. Chen,et al.  Expression of p53 in oesophageal squamous cell carcinoma in Hong Kong Chinese. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[22]  S. Tsujitani,et al.  Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma. , 1997, Journal of the American College of Surgeons.

[23]  S. Yoshida,et al.  Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy. , 1996, Japanese journal of clinical oncology.

[24]  K. Sugimachi,et al.  Correlation between reduced p21(WAF1/CIP1) expression and abnormal p53 expression in esophageal carcinomas. , 1997, International journal of oncology.

[25]  A. Zwinderman,et al.  Radiotherapy for oesophagus carcinoma: the impact of p53 on treatment outcome , 1998 .

[26]  H. Müller-Hermelink,et al.  p53 Protein in Endometrial Cancer Is Related to Proliferative Activity and Prognosis but not to Expression of p21 Protein , 1997, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[27]  S. Law,et al.  Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: A prospective clinico‐pathological study and survival analysis of 70 patients , 1997, International journal of cancer.

[28]  D. Givol,et al.  Induction of WAF1/CIP1 by a p53-independent pathway. , 1994, Cancer research.

[29]  M. Inomata,et al.  Prognostic significance of the p53 mutation in esophageal cancer. , 1996, Japanese journal of clinical oncology.

[30]  A. Børresen-Dale,et al.  Interaction between bcl‐2 and p21 (WAF1/CIP1) in breast carcinomas with wild‐type p53 , 1997, International journal of cancer.

[31]  G. Monges,et al.  Prognostic value of p53 protein expression in squamous cell carcinoma of the esophagus. , 1996, Cancer detection and prevention.

[32]  K. Hirokawa,et al.  Expression of the cyclin dependent kinase inhibitor p21WAF1/CIP1 in oesophageal squamous cell carcinomas , 1997, Virchows Archiv.

[33]  S. Nasim,et al.  Correlations between p21 expression and clincopathological finding, p53 gene and protein alteration, and survival in patients with endometrial carcinoma , 1997, The Journal of pathology.

[34]  J. Li,et al.  High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis , 1994, Cancer.

[35]  S. Elledge,et al.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.

[36]  M. Imamura,et al.  Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy. , 1997, Annals of surgery.

[37]  S. Tsao,et al.  Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. , 1997, Human pathology.